Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Class A Common Stock
-
Shares outstanding
-
28,089,346
-
Total 13F shares
-
444,149,617
-
Share change
-
+302,698,651
-
Total reported value
-
$162,115,446
-
Put/Call ratio
-
14%
-
Price per share
-
$0.3650
-
Number of holders
-
79
-
Value change
-
+$111,697,488
-
Number of buys
-
56
-
Number of sells
-
32
Institutional Holders of GeneDx Holdings Corp. - Class A Common Stock (WGS) as of Q1 2023
As of 31 Mar 2023 GeneDx Holdings Corp. - Class A Common Stock (WGS) had 79 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 444,149,617 shares of stock of the company.
Largest 10 holders included Casdin Capital, LLC, Corvex Management LP, DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), Blackstone Inc., ORACLE INVESTMENT MANAGEMENT INC, VANGUARD GROUP INC, BlackRock Inc., Soleus Capital Management, L.P., GAGNON SECURITIES LLC, and CVI Holdings, LLC.
This table shows 79 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.